ThinkEquity
http://www.thinkequity.comThinkEquity offers research, investment banking, wealth management, and asset management services for institutional and individual investors.
View Older Stories View More Recent Stories
-
Greg Hartlein Joins D.A. Davidson Investment Banking
-
Annovis Bio Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Annovis Bio Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Annovis Bio Inc. (ANVS) Prices 2M Share IPO at $6/Sh
-
Annovis Bio Announces Pricing of Initial Public Offering
-
PlacementTracker Publishes 2019 PIPE and Private Placement Markets League Tables
-
cbdMD, Inc. Announces Closing of $18.4 Million Underwritten Public Offering of Common Stock
-
cbdMD, Inc. (YCBD) Prices 16M Share Common Offering at $1/Sh
-
cbdMD, Inc. Prices Underwritten Public Offering of Common Stock
-
Better Choice Company Provides Financial Update on Halo, Purely for Pets® Acquisition
-
Cyclo Therapeutics Receives Buy Recommendation and $1.25 Price Target from ThinkEquity
-
SG Blocks Announces Closing of Public Offering
-
Sg Blocks, Inc. (SGBX) Prices 15M Share Common Offering at $0.15/Sh
-
SG Blocks Announces Pricing of Public Offering
-
DPW Holdings (DPW) Announces Rebrand of Defense Business as Gresham Worldwide and Plans to Seek Access to Public Markets
-
DPW Holdings Announces Rebrand of Defense Business as Gresham Worldwide and Plans to Seek Access to Public Markets
-
LMP Announces the Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Drone Aviation and LTE Advanced / 5G-NR Wireless Technology Provider ComSovereign Announce Merger
-
Fortress Biotech Announces Pricing of Series A Preferred Stock Offering
-
Fortress Biotech Announces Pricing of Series A Preferred Stock Offering
-
PlacementTracker Publishes Q3 2019 PIPE and Private Placement Markets League Tables
-
ThinkEquity Starts Immuron Ltd. (IMRN) at Buy
-
cbdMD, Inc. Announces Closing of $5.0 Million 8.0% Series A Cumulative Convertible Preferred Stock Offering
-
cbdMD, Inc. Announces Pricing of $5.0 Million 8.0% Series A Cumulative Convertible Preferred Stock Offering
-
BioXcel Therapeutics (BTAI) Prices 2.3M Common Stock Offering at $8.25/Share
-
BioXcel Therapeutics Announces Pricing of Public Offering of Common Stock
-
BioXcel Therapeutics (BTAI) Announces Proposed $19M Public Offering of Common Stock
-
BioXcel Therapeutics Announces Proposed Public Offering of Common Stock
-
G2 Capital Advisors Announces New Technology & Business Services Leadership Naming Jarl Berntzen Practice Leader
-
D.A. Davidson & Co. Continues Technology Investment Banking Expansion with Hiring of Steve O’Donnell
-
ThinkEquity Starts Blink Charging Co. (BLNK) at Buy
-
Celsion Corporation Reports Second Quarter 2019 Financial Results and Provides Business Update
-
Celsion Corporation Reports Second Quarter 2019 Financial Results and Provides Business Update
-
ThinkEquity Starts Quest Solutions (QUES) at Buy
-
Stemline Therapeutics (STML) Prices 5M Share Common Offering at $15.25/Sh
-
Stemline Therapeutics Announces Pricing of $76,250,000 Public Offering of Common Stock
-
SG Blocks Announces Closing of Public Offering of Common Stock
-
Sg Blocks, Inc. (SGBX) Prices 900K Share Common Offering at $0.85/Sh
-
SG Blocks Announces Pricing of Public Offering of Common Stock
-
Sg Blocks, Inc. (SGBX) Announces Proposed Public Offering of Common Stock
-
SG Blocks Announces Proposed Public Offering of Common Stock
-
PlacementTracker Publishes Q2 2019 PIPE and Private Placement Markets League Tables
-
Immuron Ltd. (IMRN) Prices 339.13K ADS Offering at $4/ADS
-
Immuron Prices Underwritten Public Offering of ADSs
-
Immuron Prices Underwritten Public Offering of ADSs
-
Immuron (IMRN) Plans Public Offering of ADSs
-
Immuron Announces Proposed Public Offering of ADSs
-
Immuron Announces Proposed Public Offering of ADSs
-
Leeds Equity Partners Hires Susan Cates, Accomplished Education Executive and Investor, as Partner
-
Ampio Pharmaceuticals Announces Closing of $12 Million Public Offering

